Back
HeartFlow
Pre-IPOOTC.HEACurrent

HeartFlow

Medical Technological Company

Company website ↗
Foundation year: 2007

About

Total Funding

$792.7M


HeartFlow is a medical technological company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFR Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan ordered by a physician to generate a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow. The HeartFlow FFRCT Analysis is commercially available in the United States, Canada, Europe, and Japan. 

Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 which became HeartFlow in May 2009. The company is headquartered in Redwood City, California. Notable investors include Panorama Point Partners, Capricorn Investment Group, and Baillie Gifford.


Number of employees

251 - 500


Headquarters

Redwood City CA, US

Investors

Baillie Gifford

Spotify, Indigo, Ginkgo Bioworks, Joby Aviation, AUTO1 Group, Carbon, Tempus, HeartFlow, Graphcore, Thumbtack

Capricorn Investment Group

QuantumScape, HeartFlow, Innovium

LifeForce Capital

HeartFlow, One Medical, Clover Health, Vineti, Verge Genomics

Martis Capital

HeartFlow

Panorama Point Partners

HeartFlow, Addepar, Porch

Rancilio Cube

HeartFlow, Taboola

Wellington Management

Swiggy, Fuze, HeartFlow, Harry's, ezCater, Omada Health, nCino, Away